Additional advantages include kidney protection and enhancements in liver function, which can mitigate obesity-related organ stress
Glucagon-like peptide-1 receptor agonists significantly increased gastric emptying T , with a large effect size (standardized mean difference, 2.38
So when one of our physicians or nurse practitioners sees a patient with obesity and we are prescribing, deprescribing, managing side effects or addressing abnormal laboratory values, we work with the PCP, we communicate with the PCP to try to create a coordinated approach so that the patient is getting excellent primary care to address the multitude of clinical conditions that they may have, while also receiving excellent specialty care to manage this underlying complicated disease state
You might start to notice minor shifts in your digestion, your energy levels, and your relationship with food
Several problems arise due to the unregulated nature of drug compounding, where the FDA does not oversee its production and the patients have no way of knowing about the exact contents of the drug